Invivyd Inc. (IVVD) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Invivyd Inc. (IVVD:NASDAQ), powered by AI.

Current Price
$1.78
P/E Ratio
-1.2
Market Cap
211M
Sector
Healthcare
What is the Invivyd Inc. stock price forecast?

Invivyd Inc. is currently trading at $1.78. View real-time AI analysis on Alpha Lenz.

What is Invivyd Inc. insider trading activity?

View the latest insider trading data for Invivyd Inc. on Alpha Lenz.

What is Invivyd Inc.'s P/E ratio?

Invivyd Inc.'s P/E ratio is -1.2.

Invivyd Inc.

NASDAQ · IVVD
$1.78
Ask about Invivyd Inc.'s future dividend policy...
Alpha Chat Insight

Invivyd Inc. trades at a P/E of -1.2 (undervalued) with modest ROE of -138.7%.

Ask for details

Company Overview

Invivyd Inc. is a biotechnology company focused on the discovery, development, and commercialization of innovative therapies to address significant unmet medical needs. Central to Invivyd's mission is its dedication to creating antibody therapies that provide potent and durable protection against a range of infectious diseases. Operating within the biotechnology sector, the company employs advanced research methodologies and cutting-edge technologies to develop its pipeline of therapeutic solutions. Invivyd Inc. is strategically positioned to impact healthcare by advancing treatments that could improve patient outcomes for diseases that currently have limited or inadequate therapeutic options. By pursuing novel antibody candidates, Invivyd plays a crucial role in public health and pharmaceutical innovation, contributing to enhanced management and prevention strategies across global healthcare markets. Its efforts reflect the growing importance of biotechnology in addressing modern healthcare challenges.

CEOMs. Heidi Spurling M.S.
SectorHealthcare
IndustryBiotechnology
Employees99

Company Statistics

FY 2024

Profile

$211.03MMarket Cap
$25.38MRevenue
0.00Shares Out
99Employees

Margins

93.63%Gross
-684.54%EBITDA
-696.80%Operating
-669.42%Pre-Tax
-669.42%Net

Valuation

-1.24P/E
3.12P/B
8.31EV/Sales
-0.82EV/EBITDA
-1.24P/FCF

Growth (CAGR)

N/ARev 3Yr
N/ARev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-94.75%ROA
-138.71%ROE
-98.62%ROIC

Financial Health

$69.35MCash & Cash Equivalents
$-7.37MNet Debt
91.76%Debt/Equity
N/AInterest Cov
Alpha Chat Insight

Invivyd Inc. trades at a P/E of -1.2 (undervalued) with modest ROE of -138.7%.

Ask for details

Frequently Asked Questions

Invivyd Inc. (ticker: IVVD) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 99 employees. Market cap is $211M.

The current price is $1.78 with a P/E ratio of -1.24x and P/B of 3.12x.

ROE is -138.71% and operating margin is -696.80%. Annual revenue is $25M.

Alpha Lenz
Singapore
CEO: Kyungtae Kim | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2025 Treasurer. All rights reserved.
Invivyd Inc. (Healthcare) Stock Forecast & Analysis $1.78 | Alpha Lenz